Canadian researchers have found a simple cure for cancer, but major pharmaceutical companies are not interested. Researchers at the University of Alberta, in Edmonton, Canada have cured cancer, yet there is little ripple in the news or on TV.
It is a simple technique using a very basic drug. The method employs dichloroacetate, which is currently used to treat metabolic disorders. So, there is no concern of side effects or any other major unwanted long term effects. This drug doesn't require a patent, so anyone can employ it widely and cheaply compared to the costly cancer drugs produced by major pharmaceutical companies.
Canadian scientists tested this dichloroacetate (DCA) on human's cells; it killed lung, breast and brain cancer cells and left the healthy cells alone. It was tested on Rats inflicted with severe tumors; the cancerous cells shrank when they were fed with water supplemented with DCA. The drug is widely available and the technique is easy to use. Why are the major drug companies not involved? Or the Media interested in this find?
In human bodies there is a natural cancer fighting organelle, the mitochondria, but they need to be triggered to be effective. Scientists used to think that these mitochondria were damaged and thus ineffective against cancer. So they used to focus on glycolysis, which is less effective in curing cancer and more wasteful. Drug manufacturers focused on this glycolysis method to fight cancer. The DCA method on the other hand doesn't rely on glycolysis but instead on mitochondria; it triggers the mitochondria which in turn fight the cancer cells.
It activates a process called apoptosis. You see, mitochondria contain an all-too-important self-destruct button that can't be pressed in cancer cells. Without it, tumors grow larger as cells refuse to be extinguished. Fully functioning mitochondria, thanks to DCA, can once again die. With glycolysis turned off, the body produces less lactic acid, so the bad tissue around cancer cells doesn't break down and seed new tumors.
Pharmaceutical companies are not investing in this research because the DCA method cannot be patented, without a patent they can't make money, like they are doing now. Since the pharmaceutical companies won't develop this, the best hope for this treatment being further pursued is via independent laboratories in collaboration with universities. However, this is only likely to be possible if the issue receives greater public attention.
In a recent paper from the World Health Organization’s International Agency for Research on Cancer (IARC), it has been reported that cases of people with cancer will surge and increase by more than 75 percent by the year 2030.
Sources:
http://stm.sciencemag.org/content/2/31/31ra34.abstract
http://www.dca.med.ualberta.ca/Home/...-15_Update.cfm
http://www.pharmainfo.net/msandhyasr...lls-mitaplatin
http://www.arbitragemagazine.com/top...4world-7debut/
http://www.nature.com/bjc/journal/v9...6604554f3.html
http://www.sott.net/articles/show/22...e-takes-notice
http://www.newscientist.com/article/...t-cancers.html